Form D — Memento Medicines, Inc.
0002139514-26-000002 · filed 2026-06-16
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $93,000,383
- Total sold
- $38,000,159
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Memento Medicines, Inc.
- CIK
- 2139514
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 200 BERKELEY ST.
BOSTON, MA 02116 - Phone
- 518-313-0994
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Naveen Manu Daryani · Executive OfficerBoston, MA Find on LinkedIn ↗
-
William Daley Bonificio · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Stephen Basil Thomas · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Zach Scheiner · DirectorBoston, MA Find on LinkedIn ↗
-
Dmitrij Hristodorov · DirectorBoston, MA Find on LinkedIn ↗
-
Megan Krench · DirectorBoston, MA Find on LinkedIn ↗
-
Vishal Kapoor · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.